Institutional investors hold a majority ownership of MRK through the 76.09% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2015, these large investors purchased a net $5.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ANIMA SGR SPA Bought 168.8 Thousand shares of Merck
STOREBRAND ASSET MANAGEMENT AS Bought 157.1 Thousand shares of Merck
STANDARD LIFE INVESTMENTS LTD. Bought 138.2 Thousand shares of Merck